Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / OPNT - Opiant Pharmaceuticals Inc. (OPNT) CEO Roger Crystal on Q3 2020 Results - Earnings Call Transcript

OPNT - Opiant Pharmaceuticals Inc. (OPNT) CEO Roger Crystal on Q3 2020 Results - Earnings Call Transcript

Opiant Pharmaceuticals Inc.
Opiant Pharmaceuticals, Inc. (OPNT) Q3 2020 Earnings Conference Call November 12, 2020 4:30 PM ET Company Participants Ben Atkins - VP, Communications & IR Roger Crystal - President, Chief Executive Officer David O'Toole - Chief Financial Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald & Co. Carl Byrnes - Northland Securities David Bautz - Zacks Investment Research Presentation Operator Greetings and welcome to the Opiant Pharmaceuticals' Third Quarter 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Ben Atkins, VP of Investor Relations Communications of Opiant Pharmaceuticals. Please go ahead. Ben Atkins Thank you, operator, and thank you, all, for joining us this afternoon. With me on today's call are Chief Executive Officer, Dr.

For further details see:

Opiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q3 2020 Results - Earnings Call Transcript
Stock Information
Company Name: Opiant Pharmaceuticals Inc.
Stock Symbol: OPNT
Market: NASDAQ
Menu
OPNT OPNT Quote OPNT Short OPNT News OPNT Articles OPNT Message Board
Get OPNT Alerts

News, Short Squeeze, Breakout and More Instantly...